Different phosphoinositide 3-kinase isoforms mediate carrageenan nociception and inflammation

Area of Science:

• Pharmacology
• Immunology
• Neuroscience

Background:

• Phosphoinositide 3-kinases (PI3Ks) are crucial signaling molecules involved in pain transmission and inflammatory processes.
• Specific PI3K isoforms play distinct roles in nociceptor activation, immune cell chemotaxis, and inflammatory mediator release.
• Understanding isoform-specific functions is key to developing targeted therapies for pain and inflammation.

Purpose of the Study:

• To investigate the specific roles of PI3K-alpha, -beta, -delta, and -gamma isoforms in carrageenan-induced pain and inflammation in rats.
• To determine if pain and inflammatory responses mediated by PI3K isoforms are pharmacologically separable.

Main Methods:

• Carrageenan-induced paw edema model in rats.
• Administration of isoform-specific PI3K antagonists (PI3K-alpha, -beta, -delta, -gamma) or vehicle prior to carrageenan injection.
• Assessment of nociception via mechanical pain threshold and spinal c-Fos expression.
• Evaluation of inflammation through paw volume, plasma extravasation, and neutrophil and macrophage infiltration.

Main Results:

• Only PI3K-gamma antagonism significantly reduced carrageenan-induced pain behaviors and spinal c-Fos expression.
• PI3K-alpha, -delta, and -gamma antagonists attenuated early inflammatory markers, including plasma extravasation, edema, and neutrophil infiltration.
• PI3K-delta and -gamma antagonists were effective in reducing later-stage edema and macrophage infiltration, with PI3K-delta showing a greater effect on edema.

Conclusions:

• Distinct PI3K isoforms mediate pain and inflammation, suggesting these processes are pharmacologically separable.
• PI3K-gamma is a key mediator of pain, while PI3K-alpha, -delta, and -gamma contribute to inflammatory responses.
• These findings provide a basis for understanding conditions where inflammation resolves but pain persists, and for developing targeted anti-inflammatory and analgesic therapies.